Should people with sickle cell disease living in malaria-endemic areas take malaria drug prophylaxis continuously? Evidence Update, Malaria Series, March 2007

From:
Department for International Development
Published
1 January 2007
Document Type:
Briefing
Theme:
Health

Abstract

Each Evidence Update is a 2-page summary of a Cochrane Review of healthcare interventions relevant to people in low-income and middle-income countries.

This Evidence Update is adapted from Oniyangi O, Omari AAA. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003489. DOI: 10.1002/14651858.CD003489.pub2.

Routine malaria drug prophylaxis is beneficial in people with homozygous sickle cell disease living in malaria endemic areas.

Citation

Effective Health Care Alliance Programme Consortium, Liverpool School of Tropical Medicine, Liverpool, UK, pp.2

Should people with sickle cell disease living in malaria-endemic areas take malaria drug prophylaxis continuously? Evidence Update, Malaria Series, March 2007

Published 1 January 2007
Contents